A process for preparing a compound of formula (I) or a pharmaceutically acceptable salt thereof according to claim 1, in which R.sub.1, R.sub.2 and R.sub.3 are defined according to claim 1, X represents an oxygen or sulphur atom or an --NH--, --GO--, methylene, ethylene, alkylidene or 1,1-cycloalkyl group containing 3 to 6 carbon atoms, Y represents an oxygen or sulphur atom, and R represents a group of formula --(CH.sub.2).sub.m --X.sub.1 --(CH.sub.2).sub.n --Z in which X.sub.1, m and n are defined according to claim 16, and Z represents a CON(R.sub.5)(R.sub.6) group in which R.sub.5 represents a hydrogen atom or a straight or branched alkyl group containing 1 to 6 carbon atoms and R.sub.6 represents a hydrogen atom or a straight or branched alkyl group containing 1 to 6 carbon atoms optionally substituted by an amino, alkylamino, dialkylamino, alkyloxy, alkylthio, alkyloxycarbonyl, carboxyl, cyano, phenyl optionally substituted by one or more identical or different groups selected from alkyloxy and trifluoromethyl groups, 1- or 2-naphthyl, 2- or 3-furyl, 2- or 3-thienyl, 4- or 5-imidazolyl, 4- or 5-thiazolyl, 2-, 3- or 4-pyridyl, indanyl, and thiochromanyl groups, wherein the alkyl portions and groups in the definition of R.sub.6 contain 1 to 4 carbon atoms, or R.sub.5 represents a hydrogen atom or a straight or branched alkyl group containing 1 to 6 carbon atoms and R.sub.6 represents a hydroxyl group, an amino group or an alkyloxy group containing 1 to 6 straight- or branched-chain carbon atoms optionally substituted by a phenyl group, said process comprising reacting a compound of formula HN(R.sub.5)(R.sub.6), in which R.sub.5 and R.sub.6 are defined as above, with a compound of formula (I) in which R.sub.1, R.sub.2, R.sub.3, X, Y, X.sub.1, m and n are defined as above and Z represents a carboxyl group, under conditions sufficient to obtain said compound of formula (I) or a salt thereof.